Enzyme replacement therapy in pediatric patients with Gaucher disease: what should we use as maintenance dosage?

Mol Genet Metab

Division of Medical Genetics, Department of Pediatrics, CHU Sainte-Justine, University of Montreal, 3175 Chemin de la Côte-Sainte-Catherine, Montreal, Que. H3T1C5, Canada.

Published: February 2009

Introduction: No consensus exists on the minimal dose of enzyme replacement therapy (ERT) effective to maintain therapeutic goals in pediatric Gaucher patients.

Objective: Evaluate the efficacy of low dosage ERT to maintain treatment goals.

Results: Six patients had a maintenance dose of 30-35U/kg/month. All patients, with the exception of one L444P/L444P homozygote, maintained therapeutic goals.

Discussion: A low maintenance dose may be adequate in most pediatric patients. L444P homozygotes may require a higher maintenance dosage.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymgme.2008.11.158DOI Listing

Publication Analysis

Top Keywords

enzyme replacement
8
replacement therapy
8
pediatric patients
8
maintenance dose
8
therapy pediatric
4
patients
4
patients gaucher
4
gaucher disease
4
maintenance
4
disease maintenance
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!